Latest News

The metaverse is the dermatologist’s ally


 

Artificial intelligence (AI) is a significant ally in dermatology and will become an indispensable component of consultations within 4 or 5 years. There are endless possibilities within the dermoverse (a term coined by joining “dermatology” and “metaverse”), from a robot office assistant to the brand new world it offers for virtual training and simulation.

A group of dermatologists expert in new technologies came together at the 50th National Congress of the Spanish Academy for Dermatology and Venereology to discuss the metaverse: that sum of all virtual spaces that bridges physical and digital reality, where users interact through their avatars and where these experts are discovering new opportunities for treating their patients. The metaverse and AI offer a massive opportunity for improving telehealth visits, immersive surgical planning, or virtual training using 3-D skin models. These are just a few examples of what this technology may eventually provide.

“The possibilities offered by the metaverse in the field of dermatology could be endless,” explained Miriam Fernández-Parrado, MD, dermatologist at Navarre Hospital, Pamplona, Spain. To her, “the metaverse could mean a step forward in teledermatology, which has come of age as a result of the pandemic.” These past few years have shown that it’s possible to perform some screenings online. This, in turn, has produced significant time and cost savings, along with greater efficacy in initial screening and early detection of serious diseases.

The overall percentage of cases that are potentially treatable in absentia is estimated to exceed 70%. “This isn’t a matter of replacing in-person visits but of finding a quality alternative that, far from dehumanizing the doctor-patient relationship, helps to satisfy the growing need for this relationship,” said Dr. Fernández-Parrado.

Always on duty

Julián Conejo-Mir, MD, PhD, professor and head of dermatology at the Virgen del Rocío Hospital in Seville, Spain, told this news organization that AI will help with day-to-day interactions with patients. It’s already a reality. “But to say that with a simple photo, we can address 70% of dermatology cases without being physically present with our patients – I don’t think that will become a reality in the next 20 years.”

Currently, algorithms can identify tumors with high success rates (80%-90%) using photographs and dermoscopic images; rates increase significantly when both kinds of images are available. These high success rates are possible because tumor morphology is stationary. “However, for inflammatory conditions, accurate diagnosis generally doesn’t exceed 60%, since these are conditions in which morphology can change a lot from one day to the next and can vary significantly, depending on their anatomic location or the patient’s age.”

Maybe once metaclinics, with 3-D virtual reality, have been established and clinicians can see the patient in real time from their offices, the rate of accurate diagnosis will reach 70%, especially with patients who have limited mobility or who live at a distance from the hospital. “But that’s still 10-15 years away, since more powerful computers are needed, most likely quantum computers,” cautioned Dr. Conejo-Mir.

The patient’s ally

In clinical practice, facilitating access to the dermoverse may help reduce pain and divert the patient’s attention, especially during in-person visits that require bothersome or uncomfortable interventions. “This is especially effective in pediatric dermatology, since settings of immersive virtual reality may contribute to relaxation among children,” explained Dr. Fernández-Parrado. She also sees potential applications among patients who need surgery. The metaverse would allow them to preview a simulation of their operation before undergoing it, thus reducing their anxiety and allaying their fears about these procedures.

Two lines are being pursued: automated diagnosis for telehealth consultations, which are primarily for tumors, and robotic office assistants.

“We have been using the first one in clinical practice, and we can achieve a success rate of 85%-90%.” The second one is much more complex, “and we’re having a hard time moving it forward within our research team, since it doesn’t involve only one algorithm. Instead, it requires five algorithms working together simultaneously (chatbot, automatic writing, image analysis, selecting the most appropriate treatment, ability to make recommendations, and even an additional one involving feelings),” explained Dr. Conejo-Mir.

A wise consultant

Dr. Conejo-Mir offered examples of how this might work in the near future. “In under 5 years, you’ll be able to sit in front of a computer or your smartphone, talk to an avatar that we’re able to select (sex, appearance, age, kind/serious), show the avatar your lesions, and it will tell us a basic diagnostic impression and even the treatment.”

With virtual learning, physicians can also gather knowledge or take refresher courses, using skin models in augmented reality with tumors and other skin lesions, or using immersive simulation courses that aid learning. Digital models that replicate the anatomy and elasticity of the skin or other characteristics unique to the patient can be used to reach decisions regarding surgeries and to practice interventions before entering the operating room, explained Dr. Fernández-Parrado.

Optimal virtual training

Virtual reality and simulation will doubtless play a major role in this promising field of using these devices for training purposes. “There will be virtual dermatology clinics or metaclinics, where you can do everything with virtual simulated patients, from gaining experience in interviews or health histories (even with patients who are difficult to deal with), to taking biopsies and performing interventions,” said Dr. Conejo-Mir.

A recent study titled “How the World Sees the Metaverse and Extended Reality” gathered data from 29 countries regarding the next 10 years. One of the greatest benefits of this technology is expected in health resources (59%), even more than in the trading of digital assets. While it is difficult to predict when the dermoverse will be in operation, Dr. Fernández-Parrado says she’s a techno-optimist. Together with Dr. Héctor Perandones, MD, a dermatologist at the University Healthcare Complex in León, Spain, and coauthor with Dr. Fernández-Parrado of the article, “A New Universe in Dermatology: From Metaverse to Dermoverse,” she’s convinced that “if we can imagine it, we can create it.”

Pages

Recommended Reading

The enemy of carcinogenic fumes is my friendly begonia
MDedge Dermatology
Is ChatGPT a friend or foe of medical publishing?
MDedge Dermatology
Protecting your practice data
MDedge Dermatology
New bill would provide greater length of time to sue doctors
MDedge Dermatology
After Yusimry’s steep discount, little clarity on future adalimumab biosimilar pricing
MDedge Dermatology
How not to establish rapport with your patient
MDedge Dermatology
Proposal to cap Part B pay on some drugs draws opposition
MDedge Dermatology
Low-calorie tastes sweeter with a little salt
MDedge Dermatology
Should you dismiss a difficult patient?
MDedge Dermatology
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get meds
MDedge Dermatology